News About: Pharm. Industry
Pharmaceutical companies stepping up training programs for business personnel
There is growing tendency that domestic pharmaceuticals firms are gearing up their efforts to ensure better detailing capacity of sales personnel and nurture able medical representatives through a wide range of traini...
Janssen Korea intensifies effort to boost sales
Janssen Korea said recently that it would launch Velcade (bortezomib) injection, a new treatment for multiple myeloma, a cancer of the bone marrow, within this year in addition to Sporanox (itraconazole) for the treat...
Pharmaceutical overseas business to be supported.
Many supporting programs seemed to be provided by various authorities including Korea Health Industry Development Institute (KHIDI) for the pharmaceutical overseas business entry by means of dispatching overseas marke...
Samjin and Iljin to form functional food distribution corporation.
The enforcement of the Functional Health Food Act has enticed many pharmaceutical and cosmetic companies to enter the health functional food business.
Samjin Pharmaceutical company and Iljin Pharmaceutical compa...
GSK Korea target 250 billion sales revenue this year
GlaxoSmithKline Korea said that it is aiming for a 250 billion won in sales revenue this year, up 1.2 percent against sales revenue of 220 billion won in 2003.
To that end, the company said it selected 11 unit he...
Sanofi-Synthelabo's REACH Registry launched to increase knowledge of atherothrombosis
Sanofi-Synthelabo announced recently the launch of the REACH (REduction of Atherothrombosis for Continued Health) Registry, one of the largest international registries ever conducted in people at risk of atherothrombo...
PDC expediting earlier settlement on NHI drug pricing deals.
Pharmaceutical Development Council (PDC: chairman: Kim Jeong-soo) took a meeting at Tower hotel on Jan. 19 and agreed to request all related drug companies to settle down the payment of sales allowances and the price ...
Patent application for anti-bird flu virus composites.
EnBiotechnologies announced on Jan. 19 to have earlier filed a patent registration for HIN2 type of anti-bird flu virus composites containing a water soluble Glycan Oligomo of yeast under the patent application No. 10...
Local nifedipine market seen intensifying
The domestic nifedipine market is expected to intensify this year, as some Korean companies such as Hanmi Pharm and Pacific Pharm plan to launch new formulations within the year in the hope of carving out bigger marke...
1,259 drugs to delete from NHI reimbursement.
Taking effect from Feb. 1, 2004 the total 1,259 drugs will be deleted from the NHI reimbursement schedule due to no production so far.
HIRA announced a public notification titled "NHI reimbursable or non-reimbursab...
